Invent targeted small molecule drugs
that are either first-in-class or second-generation

Selectively develop our drugs
to maximize their overall value

Perform a partnering strategy
in which we retain profit rights for drugs
through partner select early-stage programs

ABOUT US

BiSiChem is a leading biotech company that focused on the discovery and
development of innovative therapeutic drugs on immuno-oncology,
targeted therapy and neuro-degenerative diseases.

Our goals are Good lives, Better innovation and Best therapy.

HISTORY
LEADERSHIP

Our main focus is
¡°BiSiChem is a precision medicine company
developing a specific targeted therapy to treat cancer.¡±

VISION OF SCIENCE

Breakthrough discovery of therapeutics for unmet medical needs,
biomarker-based innovative, first-in-class or best-in-class candidates development

pipeline
develpment strategy
Research center

BiSiChem has a strength on preclinical candidate selection by target selection,
medicinal chemistry, biology and DMPK experties.

R&D Research Center. Pangyo

New Drug Research Center. Yongin

COLLABORATION

Lifex Biolabs Inc.

Therapex Crop.

Asan Medical Center

KNU SCHOOL OF MEDICINE

contact
address

1006, C-dong, 357,
Guseong-ro, Giheung-gu,
Yongin-si, Gyeonggi-do,
Republic of Korea

Contact

Tel +82-31-698-3772
Fax +82-70-7610-2776
E-mail bsc@bisichem.com

Map

kakao map